-
Leading the way is Targacept, a company spun out of the research division of R.
FORBES: Magazine Article
-
If Targacept's drug succeeds, it would be a welcome addition to the existing options for treating Alzheimer's.
FORBES: The Nicotine Cure
-
Reynolds never sold any of its stake in Targacept, but dilution has lowered its equity interest to 4%.
FORBES: Magazine Article